CALAIS PHILIPPE enters TRANSCODE THERAPEUTICS, INC. with 127.38K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/8/2021ACC: 0001104659-21-090401
Director
Since Jul 2021
127.38K
Baseline shares
100% direct
127.38K
Direct ownership
1 position
36.39K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned127.38K
Total
127.38K direct127.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 127.38K | Direct |
| Total | 127.38K | 127.38K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
36.39K
Shares owned
N/A
Exercise price
3.907
Expiration
—
Exercise window
—
Total
Underlying
36.39K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 3.907 | — | — | 36.39K | N/A |
| Total | 36.39K | 0.00 | ||||